4423 related articles for article (PubMed ID: 6667339)
1. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
Yagi MJ; Bekesi JG
Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
[TBL] [Abstract][Full Text] [Related]
2. Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agent.
Yagi MJ; Maldarelli F; Chin SE; Holland JF; Bekesi JG
J Natl Cancer Inst; 1986 Mar; 76(3):493-501. PubMed ID: 3005743
[TBL] [Abstract][Full Text] [Related]
3. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
[TBL] [Abstract][Full Text] [Related]
4. Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.
Yagi MJ; Zanjani M; Holland JF; Bekesi JG
Cancer Chemother Pharmacol; 1984; 12(2):77-82. PubMed ID: 6697428
[TBL] [Abstract][Full Text] [Related]
5. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.
Yagi MJ; Bekesi JG; Daniel MD; Holland JF; De Barbieri A
Cancer Chemother Pharmacol; 1984; 12(2):70-6. PubMed ID: 6421500
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.
Yagi MJ; Bekesi JG
Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770
[TBL] [Abstract][Full Text] [Related]
7. Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids.
Yagi MJ; Scanlon KJ; Chin SE; Bekesi JG
Chemotherapy; 1988; 34(1):61-70. PubMed ID: 2832130
[TBL] [Abstract][Full Text] [Related]
8. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids.
Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG
Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661
[TBL] [Abstract][Full Text] [Related]
9. Immunopharmacological studies of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative.
Allegrucci M; Ballerini P; Romani L; Frati L
Immunopharmacol Immunotoxicol; 1987; 9(1):71-86. PubMed ID: 3450712
[TBL] [Abstract][Full Text] [Related]
10. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
Roboz J; Jiang J; Holland JF; Bekesi JG
Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
[TBL] [Abstract][Full Text] [Related]
11. Attempted drug-tumor sensitivity matching using diffusion chamber-cultivated cells.
Mason BH; Cain BF
Cancer Treat Rep; 1978 Dec; 62(12):2035-43. PubMed ID: 751713
[No Abstract] [Full Text] [Related]
12. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
Catsoulacos P; Catsoulacos D
Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, acute toxicity and chemotherapeutic anti-cancer activities of a new tripeptidic mustard.
De Barbieri A; Dall'Asta L; Comini A; Springolo V; Mosconi P; Coppi G
Farmaco Sci; 1983 Apr; 38(4):205-18. PubMed ID: 6861998
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM).
Lemoli RM; Visani G; Tosi P; Mazza P; Motta MR; Rizzi S; Zinzani PL; Poluzzi C; Gherlinzoni F; Tura S
Haematologica; 1988; 73(3):195-200. PubMed ID: 3139515
[No Abstract] [Full Text] [Related]
15. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
16. Antileukemic effect of homo-aza-steroidal ester of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid.
Wampler GL; Catsoulacos P
Cancer Treat Rep; 1977; 61(1):37-41. PubMed ID: 861962
[TBL] [Abstract][Full Text] [Related]
17. Analytical and pharmacological studies on a new antineoplastic tripeptide, PTT.119.
Roboz J; Greaves J; Yagi MJ; Holland JF; Bekesi JG
Pharmacology; 1985; 30(1):52-9. PubMed ID: 3975256
[TBL] [Abstract][Full Text] [Related]
18. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
Schmid FA; Otter GM; Mehta BM
Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147
[TBL] [Abstract][Full Text] [Related]
19. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
20. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
